Introduction to a review series on myelodysplastic syndromes in the age of genomic medicine

被引：0
|
作者：
Cazzola, Mario
机构：
来源：
BLOOD | 2023年 / 142卷 / 26期
关键词：
CLASSIFICATION; PROPOSALS;
D O I：
10.1182/blood.2023022912
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2223 / 2223
页数：1
相关论文
共 50 条
  • [41] Myelodysplastic syndromes in patients younger than age 50
    Kuendgen, Andrea
    Strupp, Corinna
    Aivado, Manuel
    Hildebrandt, Barbara
    Haas, Rainer
    Gattermann, Norbert
    Germing, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5358 - 5365
  • [42] No increase in age-specific incidence of myelodysplastic syndromes
    Germing, U
    Strupp, C
    Kündgen, A
    Bowen, D
    Aul, C
    Haas, R
    Gattermann, N
    HAEMATOLOGICA, 2004, 89 (08) : 905 - 910
  • [43] The relationship between age and karyotypic abnormalities in myelodysplastic syndromes
    Wong, KF
    Hayes, KJ
    Leung, S
    Glassman, AB
    CANCER GENETICS AND CYTOGENETICS, 1996, 88 (01) : 80 - 82
  • [44] Precision medicine for early detection of clonal evolution in myelodysplastic syndromes
    Makishima, Hideki
    Yoshizato, Tetsuichi
    Yoshida, Kenichi
    Nannya, Yasuhito
    Nagata, Yasunobu
    Okuno, Yusuke
    Shiraishi, Yuichi
    Chiba, Shigeru
    Miyano, Satoru
    Shih, Lee-Yung
    Haferlach, Torsten
    Maciejewski, Jaroslaw P.
    Ogawa, Seishi
    CANCER SCIENCE, 2018, 109 : 549 - 549
  • [45] Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
    Chanias, Ioannis
    Stojkov, Kristina
    Stehle, Gregor Th.
    Daskalakis, Michael
    Simeunovic, Helena
    Njue, Linet Muthoni
    Schnegg-Kaufmann, Annatina S.
    Porret, Naomi A.
    Allam, Ramanjaneyulu
    Rao, Tata Nageswara
    Benz, Rudolf
    Ruefer, Axel
    Schmidt, Adrian
    Adler, Marcel
    Rovo, Alicia
    Balabanov, Stefan
    Stuessi, Georg
    Bacher, Ulrike
    Bonadies, Nicolas
    CANCERS, 2021, 13 (13)
  • [46] Comprehensive Genomic Evaluation For Inherited Bone Marrow Failure/Myelodysplastic Syndromes
    Zhang, Michael
    Keel, Sioban B.
    Walsh, Tom
    Lee, Ming
    Colin, Pritchard
    Jeng, Michael
    Watts, Amanda
    Abkowitz, Janis L.
    King, Mary Claire
    Shimamura, Akiko
    BLOOD, 2013, 122 (21)
  • [47] Genomic imbalances in 139 patients with myelodysplastic syndromes (MDS) and complex karyotypes
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Buryova, Halka
    Kostylkova, Karla
    Bystricka, Dagmar
    Novakova, Milena
    Sarova, Iveta
    Izakova, Silvia
    Lizcova, Libuse
    Ransdorfova, Sarka
    Zmolikova, Jana
    Siskova, Magda
    Cermak, Jaroslav
    CHROMOSOME RESEARCH, 2013, 21 : S92 - S93
  • [48] Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes
    Abaigar, Maria
    Robledo, Cristina
    Benito, Rocio
    Ramos, Fernando
    Diez-Campelo, Maria
    Hermosin, Lourdes
    Sanchez-del-Real, Javier
    Alonso, Jose M.
    Cuello, Rebeca
    Megido, Marta
    Rodriguez, Juan N.
    Martin-Nunez, Guillermo
    Aguilar, Carlos
    Vargas, Manuel
    Martin, Ana A.
    Garcia, Juan L.
    Kohlmann, Alexander
    Consuelo del Canizo, M.
    Hernandez-Rivas, Jesus M.
    PLOS ONE, 2016, 11 (10):
  • [49] Genomic and Clinical Heterogeneity in TP53 Mutant Myelodysplastic Syndromes
    Coty-Fattal, Zachary
    Sukhanova, Madina
    Lu, Xinyan
    Wolniak, Kristy
    Gao, Juehua
    Behdad, Amir
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 934 - 935
  • [50] The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromes
    Steensma, David P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (04) : 295 - 300
12345